Association of aryl hydrocarbon receptor and cytochrome P4501B1 expressions in human non-small cell lung cancers

Author： Lin P. Chang H. Ho W.L. Wu M.-H. Su J.-M.

Publisher： Elsevier

ISSN： 0169-5002

Source： Lung Cancer, Vol.42, Iss.3, 2003-12, pp. : 255-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism

By Larsen Jill

Cancer Causes and Control, Vol. 16, Iss. 5, 2005-06 ,pp. : 579-585

Springer Publishing Company

Access to resources Recommend Favorite

The expressions and clinical significance of P53, C-erbB-2 and VEGF in non-small cell lung cancer

By Gu Aiqin

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 2, 2008-02 ,pp. : 78-80

Springer Publishing Company

Access to resources Recommend Favorite

Gene expression profiles in human non-small and small-cell lung cancers

By Difilippantonio S. Chen Y. Pietas A. Schluns K. Pacyna-Gengelbach M. Deutschmann N. Padilla-Nash H.M. Ried T. Petersen I.

European Journal of Cancer, Vol. 39, Iss. 13, 2003-09 ,pp. : 1936-1947

Elsevier

Access to resources Recommend Favorite

The expression and significance of cyclin B1 and survivin in human non-small cell lung cancer

By Li Guosheng Liu Xuhan Zhang Daorong Liu Dong Li Zhiyong

The Chinese-German Journal of Clinical Oncology, Vol. 10, Iss. 4, 2011-04 ,pp. : 192-197

Springer Publishing Company

Access to resources Recommend Favorite

Combined inhibition of insulin-like growth factor-1 receptor enhances the effects of gefitinib in a human non-small cell lung cancer resistant cell line

By Qi Hui wei Shen Zan Fan Li hong

Experimental and Therapeutic Medicine, Vol. 2, Iss. 6, 2011-11 ,pp. : 1091-1095

Spandidos Publications

Access to resources Recommend Favorite